{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:38Z","timestamp":1792789838043,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T00:00:00Z","timestamp":1706400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02945-0","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T05:02:43Z","timestamp":1706418163000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"57","author":[{"given":"Larissa A.","family":"de Lucena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos A. A.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana K. C.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroliny H. A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine M. F.","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe L.","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose B.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1617-6759","authenticated-orcid":false,"given":"Rodrigo A.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,28]]},"reference":[{"key":"2945_CR1","doi-asserted-by":"publisher","unstructured":"Magalh\u00e3es L, Figueiredo M, Cintra F et al (2016) II diretrizes Brasileiras De Fibrila\u00e7\u00e3o Atrial. Arquivos brasileiros de cardiologia 106(4). https:\/\/doi.org\/10.5935\/abc.20160055","DOI":"10.5935\/abc.20160055"},{"issue":"8","key":"2945_CR2","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ et al (2021) Heart disease and stroke statistics \u2013\u20092021 update: a report from the American Heart Association. Circulation 143(8):e254\u2013e743. https:\/\/doi.org\/10.1161\/CIR.0000000000000950","journal-title":"Circulation"},{"issue":"2","key":"2945_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1681\/ASN.2010050459","volume":"22","author":"WC Winkelmayer","year":"2011","unstructured":"Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S (2011) The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22(2):349\u2013357. https:\/\/doi.org\/10.1681\/ASN.2010050459","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2945_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/rth2.12250","volume":"3","author":"O K\u00f6nigsbr\u00fcgge","year":"2019","unstructured":"K\u00f6nigsbr\u00fcgge O, Ay C (2019) Atrial fibrillation in patients with end-stage renal disease on hemodialysis: magnitude of the problem and new approach to oral anticoagulation. Res Pract Thromb Haemost 3(4):578\u2013588 Published 2019 Aug 18. https:\/\/doi.org\/10.1002\/rth2.12250","journal-title":"Res Pract Thromb Haemost"},{"issue":"9","key":"2945_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1161\/STROKEAHA.115.009095","volume":"46","author":"MD Findlay","year":"2015","unstructured":"Findlay MD, Thomson PC, Fulton RL et al (2015) Risk factors of ischemic stroke and subsequent outcome in patients receiving hemodialysis. Stroke 46(9):2477\u20132481. https:\/\/doi.org\/10.1161\/STROKEAHA.115.009095","journal-title":"Stroke"},{"issue":"2","key":"2945_CR6","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H et al (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation 140(2):e125\u2013e151. https:\/\/doi.org\/10.1161\/CIR.000000000000665","journal-title":"Circulation"},{"key":"2945_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ahj.2016.09.016","volume":"184","author":"H Van Der Meersch","year":"2017","unstructured":"Van Der Meersch H, De Bacquer D, De Vriese AS (2017) Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis. Am Heart J 184:37\u201346. https:\/\/doi.org\/10.1016\/j.ahj.2016.09.016","journal-title":"Am Heart J"},{"issue":"17","key":"2945_CR8","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","volume":"74","author":"S Kumar","year":"2019","unstructured":"Kumar S, Lim E, Covic A et al (2019) Anticoagulation in concomitant chronic kidney Disease and Atrial Fibrillation: JACC Review topic of the Week. J Am Coll Cardiol 74(17):2204\u20132215. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1031","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2945_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2217\/fca-2021-0120","volume":"18","author":"S Deitelzweig","year":"2022","unstructured":"Deitelzweig S, Bergrath E, di Fusco M et al (2022) Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol 18(5):393\u2013405. https:\/\/doi.org\/10.2217\/fca-2021-0120","journal-title":"Future Cardiol"},{"issue":"3","key":"2945_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.31083\/j.fbs1403021","volume":"14","author":"N Ktenopoulos","year":"2022","unstructured":"Ktenopoulos N, Sagris M, Theofilis P, Lionaki S, Rallidis LS (2022) Direct oral anticoagulants in patients on chronic Dialysis and concomitant Atrial Fibrillation: a Common Clinical Impasse. Front Biosci (Schol Ed) 14(3):21. https:\/\/doi.org\/10.31083\/j.fbs1403021","journal-title":"Front Biosci (Schol Ed)"},{"issue":"6","key":"2945_CR11","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2020111566","volume":"32","author":"AS De Vriese","year":"2021","unstructured":"De Vriese AS, Caluw\u00e9 R, Van Der Meersch H, De Boeck K, De Bacquer D (2021) Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis patients with Atrial Fibrillation: a Multicenter Randomized Controlled Trial. J Am Soc Nephrol 32(6):1474\u20131483. https:\/\/doi.org\/10.1681\/ASN.2020111566","journal-title":"J Am Soc Nephrol"},{"issue":"23","key":"2945_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","volume":"146","author":"SD Pokorney","year":"2022","unstructured":"Pokorney SD, Chertow GM, Al-Khalid HR et al (2022) Apixaban for patients with Atrial Fibrillation on hemodialysis: a Multicenter Randomized Controlled Trial. Circulation 146(23):1735\u20131745. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054990","journal-title":"Circulation"},{"issue":"4","key":"2945_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","volume":"147","author":"H Reinecke","year":"2023","unstructured":"Reinecke H, Engelbertz C, Bauersachs R et al (2023) A randomized controlled trial comparing Apixaban with the Vitamin K Antagonist Phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study. Circulation 147(4):296\u2013309. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062779","journal-title":"Circulation"},{"key":"2945_CR14","doi-asserted-by":"publisher","first-page":"847286","DOI":"10.3389\/fcvm.2022.847286","volume":"9","author":"S Elfar","year":"2022","unstructured":"Elfar S, Elzeiny SM, Ismail H, Makkeyah Y, Ibrahim M (2022) Direct oral anticoagulants vs. Warfarin in Hemodialysis patients with Atrial Fibrillation: a systematic review and Meta-analysis. Front Cardiovasc Med 9:847286 Published 2022 Jun 9. https:\/\/doi.org\/10.3389\/fcvm.2022.847286","journal-title":"Front Cardiovasc Med"},{"key":"2945_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928. Published 2011 Oct 18","journal-title":"BMJ"},{"key":"2945_CR16","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, Available from www.training.cochrane.org\/handbook"},{"key":"2945_CR17","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. ;372:n71. Published 2021 Mar 29. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"11","key":"2945_CR18","doi-asserted-by":"publisher","first-page":"CD011373","DOI":"10.1002\/14651858.CD011373.pub2","volume":"11","author":"M Kimachi","year":"2017","unstructured":"Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S (2017) Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev 11(11):CD011373 Published 2017 Nov 6. https:\/\/doi.org\/10.1002\/14651858.CD011373.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2945_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"issue":"22","key":"2945_CR20","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093\u20132104. https:\/\/doi.org\/10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"},{"key":"2945_CR21","doi-asserted-by":"publisher","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2010) Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in N Engl J Med. ;363(19):1877]. N Engl J Med. 2009;361(12):1139\u20131151. https:\/\/doi.org\/10.1056\/NEJMoa0905561","DOI":"10.1056\/NEJMoa0905561"},{"key":"2945_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.amjcard.2023.08.116","volume":"206","author":"M Faisaluddin","year":"2023","unstructured":"Faisaluddin M, Alwifati N, Naeem N et al (2023) Safety and efficacy of direct oral anticoagulants Versus Warfarin for Atrial Fibrillation in End-Stage Renal Disease on hemodialysis: a Meta-analysis of Randomized Control trials. Am J Cardiol 206:309\u2013311. https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.116","journal-title":"Am J Cardiol"},{"key":"2945_CR23","unstructured":"Food and Drug Association (2012) HIGHLIGHTS of PRESCRIBING INFORMATION: Eliquis. FDA\/CDER. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/202155s000lbl.pdf. Accessed 30 May 2023"},{"issue":"15","key":"2945_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","volume":"138","author":"KC Siontis","year":"2018","unstructured":"Siontis KC, Zhang X, Eckhard A et al (2018) Outcomes Associated with Apixaban Use in patients with end-stage kidney Disease and Atrial Fibrillation in the United States. Circulation 138(15):1519\u20131529. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035418","journal-title":"Circulation"},{"issue":"1","key":"2945_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.ajkd.2015.01.022","volume":"66","author":"AS De Vriese","year":"2015","unstructured":"De Vriese AS, Caluw\u00e9 R, Bailleul E et al (2015) Dose-finding study of rivaroxaban in hemodialysis patients. Am J Kidney Dis 66(1):91\u201398. https:\/\/doi.org\/10.1053\/j.ajkd.2015.01.022","journal-title":"Am J Kidney Dis"},{"key":"2945_CR26","unstructured":"Food and Drug Association (2014) HIGHLIGHTS of PRESCRIBING INFORMATION: Xarelto. FDA\/CDER. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/022406s015lbl.pdf. Accessed 30 May 2023"},{"issue":"22","key":"2945_CR27","doi-asserted-by":"publisher","first-page":"00621","DOI":"10.1053\/j.ajkd.2022.03.007","volume":"S0272\u20136386","author":"JB Wetmore","year":"2022","unstructured":"Wetmore JB, Weinhandl ED, Yan H et al (2022) Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: a retrospective cohort study. Am J Kidney Dis S0272\u20136386(22):00621\u201300627. https:\/\/doi.org\/10.1053\/j.ajkd.2022.03.007","journal-title":"Am J Kidney Dis"},{"key":"2945_CR28","doi-asserted-by":"publisher","unstructured":"Kuno T, Takagi H, Ando T et al (2020) Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis [published correction appears in J Am Coll Cardiol. ;75(7):842]. J Am Coll Cardiol. 2020;75(3):273\u2013285. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.059","DOI":"10.1016\/j.jacc.2019.10.059"},{"issue":"3","key":"2945_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.36660\/abc.20210805","volume":"119","author":"KNDS Malagutte","year":"2022","unstructured":"Malagutte KNDS, Silveira CFSMP, Reis FM et al (2022) Qualidade Da Anticoagula\u00e7\u00e3o oral em pacientes com Fibrila\u00e7\u00e3o Atrial em um Hospital Terci\u00e1rio no Brasil. Arquivos brasileiros de cardiologia 119(3):363\u2013369. https:\/\/doi.org\/10.36660\/abc.20210805","journal-title":"Arquivos brasileiros de cardiologia"},{"issue":"2","key":"2945_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5414\/CN108400","volume":"83","author":"LM Quinn","year":"2015","unstructured":"Quinn LM, Richardson R, Cameron KJ et al (2015) Evaluating time in therapeutic range for hemodialysis patients taking warfarin. Clin Nephrol 83(2):80\u201385. https:\/\/doi.org\/10.5414\/CN108400","journal-title":"Clin Nephrol"},{"key":"2945_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2369-12-46","volume":"12","author":"BK Thomson","year":"2011","unstructured":"Thomson BK, MacRae JM, Barnieh L et al (2011) Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients. BMC Nephrol 12:46. https:\/\/doi.org\/10.1186\/1471-2369-12-46","journal-title":"BMC Nephrol"},{"issue":"3","key":"2945_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/ndt\/gfu334","volume":"30","author":"S Genovesi","year":"2015","unstructured":"Genovesi S, Rossi E, Gallieni M et al (2015) Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. Nephrol Dial Transplant 30(3):491\u2013498. https:\/\/doi.org\/10.1093\/ndt\/gfu334","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02945-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02945-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02945-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T20:03:26Z","timestamp":1711310606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02945-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,28]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2945"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02945-0","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,28]]},"assertion":[{"value":"29 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required because this study retrieved and synthesized data from previously published studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}